Business, energy, technology, markets and global industry news from Business News Today

vutrisiran

Pharma & Biotech

Aurisco passed an FDA inspection for inclisiran sodium, but the bigger story is what comes next for generic oligonucleotides

Aurisco’s FDA inspection for inclisiran sodium puts generic oligonucleotide manufacturing closer to a crucial regulatory and commercial test.

Read More
Pharma & Biotech

Can Alnylam’s AMVUTTRA become a first-line treatment force in ATTR-CM?

ATTR-CM treatment is shifting earlier. Alnylam must now prove AMVUTTRA can win clinician trust beyond trial subgroups.

Read More
Pharma & Biotech

How Alnylam Pharmaceuticals is using new ACC.26 data to deepen the case for vutrisiran and zilebesiran

See why Alnylam Pharmaceuticals’ new ACC.26 data on vutrisiran and zilebesiran could reshape cardiovascular strategy and market expectations.

Read More